Currently out of the existing stock ratings of Eric Criscuolo, 20 are a HOLD (57.14%), 1 are a SELL (2.86%), 14 are a BUY (40%).

Eric Criscuolo

Work Performance Price Targets & Ratings Chart

Analyst Eric Criscuolo, carries an average stock price target met ratio of 94.44% that have a potential upside of 15.05% achieved within 237 days. Previously, Eric Criscuolo worked at MIZUHO.

Eric Criscuolo’s has documented 63 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CLVS, Clovis Oncology at 24-Aug-2016.

Wall Street Analyst Eric Criscuolo

Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 6/15/2016. The price target of $10 was fulfilled within 1 day with a profit of $0.67 (7.18%) receiving and performance score of 71.81.

Average potential price target upside

of $20.63 (13.98%) on TMO (THERMO FISHER SCIENTIFIC).
of $12.89 (9.47%) on ILMN (ILLUMINA).
of $3.46 (7.88%) on MYGN (MYRIAD GENETICS).

EXAS EXACT Sciences ILMN Illumina MYGN Myriad Genetics TMO Thermo Fisher Scientific CLVS Clovis Oncology FLDM Fluidigm PKI PerkinElmer XON Precigen LAB Standard Biotools

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Kyle Mikson (CANACCORD)